The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Busulfan Overdose in the Conditioning for BMT.
 
Naotoshi Sugimoto
Research Funding - Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly; MSD Oncology; Ono Pharmaceutical; Taiho Pharmaceutical
 
Chu Matsuda
No Relationships to Disclose
 
Taishi Hata
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)
 
Masakazu Ikenaga
No Relationships to Disclose
 
Tsunekazu Mizushima
No Relationships to Disclose
 
Kohei Murata
No Relationships to Disclose
 
Masayuki Ohue
Research Funding - Chugai Pharma; Taiho Pharmaceutical
 
Yuichiro Doki
No Relationships to Disclose
 
Masaki Mori
No Relationships to Disclose